Midlife Growth Hormone Receptor Ablation Extends Healthy Lifespan and Induces Sex‐Specific Hepatic Transcriptional Changes at Single‐Cell Resolution
Key claim: Midlife ablation of the growth hormone receptor extends healthy lifespan and induces sex-specific hepatic transcriptional changes at single-cell resolution.
Abstract
Aging Cell, Volume 25, Issue 9, September 2026.
Why this matters
Congenital GHR knockout mice (and human Laron syndrome) established the GH/IGF-1 axis as a canonical longevity lever, but the intervention-relevant question has always been whether adult-onset suppression captures the same benefit without developmental costs. A midlife GHR ablation that extends healthy lifespan pushes the axis toward translational plausibility and, via sex-specific single-cell hepatic transcriptomics, begins to specify which cell populations and programs mediate the effect — a prerequisite for any adult GH/IGF-1-lowering therapeutic pitch.